Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): Emerging commercial opportunities

Current Topics in Medicinal Chemistry

Volumn 5, Issue 7, 2005, Pages 625-636

  Keefer, Larry K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ANTINEOPLASTIC AGENT; ARSENITE SODIUM; BOVINE SERUM ALBUMIN; CB 3100; CIPROFLOXACIN; CISPLATIN; DIAZENIUMDIOLATE DERIVATIVE; FLUOROURACIL DERIVATIVE; HEPARIN DERIVATIVE; IBUPROFEN DERIVATIVE; JS K; NICOTINIC ACID DERIVATIVE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE DONOR; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID DERIVATIVE; PRODRUG; UNCLASSIFIED DRUG;

ACCURACY; BACTERIUM ADHERENCE; BIOCOMPATIBILITY; BIOFOULING; BIOSENSOR; BLOOD VESSEL GRAFT; CLINICAL TRIAL; COMMERCIAL PHENOMENA; DERIVATIZATION; DRUG DESIGN; DRUG DOSAGE FORM; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG MARKETING; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG RESEARCH; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVATION; EXPERIMENTAL NEOPLASM; HUMAN; IN-STENT RESTENOSIS; MEDICAL INSTRUMENTATION; MEDICAL TECHNOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; PATENT; PHOTOLYSIS; RELIABILITY; REVIEW; SHELF LIFE; STOMACH DISEASE; SURGICAL EQUIPMENT; THROMBOSIS; WOUND HEALING;

ANIMALS; AZO COMPOUNDS; DRUG DESIGN; EQUIPMENT AND SUPPLIES; HUMANS; NITRIC OXIDE; NITROGEN OXIDES;

EID: 23844458342     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026054679380     Document Type: Review

References (97)

1. Frost M. C.; Reynolds, M. M. & Meyerhoff, M. E. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices. Biomaterials 2005, 26, 1685-93.
2. Zhou, Z. and Meyerhoff, M. E. Polymethacrylate-based nitric oxide donors with pendant N-diazeniumdiolated alkyldiamine moieties: Synthesis, characterization, and preparation of nitric oxide releasing polymeric coatings. Biomacromolecules 2005, 6, 780-9.
3. Batchelor, M. M.; Reoma, S. L.; Fleser, P. S.; Nuthakki, V. K.; Callahan, R. E.; Shanley, C. J.; Politis, J. K.; Elmore, J.; Merz, S. I. & Meyerhoff, M. E. More lipophilic dialkyldiamine-based diazeniumdiolates: Synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. J. Med. Chem. 2003, 46, 5153-61.
4. Dobmeier, K. P. and Schoenfisch, M. H. Antibacterial properties of nitric oxide-releasing sol-gel microarrays. Biomacromolecules 2004, 5, 2493-5.
5. Robbins, M. E.; Hopper, E. D. & Schoenfisch, M. H. Synthesis and characterization of nitric oxide-releasing sol-gel microarrays. Langmuir 2004, 20, 10296-302.
6. Do, Y. S.; Kao, E. Y.; Ganaha, F.; Minamiguchi, H.; Sugimoto, K.; Lee, J.; Elkins, C. J.; Amabile, P. G.; Kuo, M. D.; Wang, D. S.; Waugh, J. M. & Dake, M. D. In-stent restenosis limitation with stent-based controlled-release nitric oxide: Initial results in rabbits. Radiology 2004, 230, 377-82.
7. Fleser, P. S.; Nuthakki, V. K.; Malinzak, L. E.; Callahan, R. E.; Seymour, M. L.; Reynolds, M. M.; Merz, S. I.; Meyerhoff, M. E.; Bendick, P. J.; Zelenock, G. B. & Shanley, C. J. Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts. J. Vasc. Surg. 2004, 40, 803-11.
8. Oh, B. K.; Robbins, M. E.; Nablo, B. J. & Schoenfisch, M. H. Miniaturized glucose biosensor modified with a nitric oxide-releasing xerogel microarray. Biosensors & Bioelectronics 2005, in press.
9. Gill, S. and Sinicrope, F. A. Colorectal cancer prevention: Is an ounce of prevention worth a pound of cure? Semin. Oncol. 2005, 32, 24-34.
10. Baek, S. H.; Hrabie, J. A.; Keefer, L. K.; Hou, D.; Fineberg, N.; Rhoades, R. & March, K. L. Augmentation of intrapericardial nitric oxide level by a prolonged-release nitric oxide donor reduces luminal narrowing after porcine coronary angioplasty. Circulation 2002, 105, 2779-84.
11. Saavedra, J. E.; Mooradian, D. L.; Mowery, K. A.; Schoenfisch, M. H.; Citro, M. L.; Davies, K. M.; Meyerhoff, M. E. & Keefer, L. K. Conversion of a polysaccharide to nitric oxide-releasing form. Dual-mechanism anticoagulant activity of diazeniumdiolated heparin. Bioorg. Med. Chem. Lett. 2000, 10, 751-3.
12. Velázquez, C. and Knaus, E. E. Synthesis and biological evaluation of 1,4-dihydropyridine calcium channel modulators having a diazen-1-ium-1,2-diolate nitric oxide donor moiety for the potential treatment of congestive heart failure. Bioorg. Med. Chem. 2004, 12, 3831-40.
13. Nguyen, J.-T., Velázquez, C. A. & Knaus, E. E. Hantzsch 1,4-dihydropyridines containing a diazen-1-ium-1,2-diolate nitric oxide donor moiety to study calcium channel antagonist structure-activity relationships and nitric oxide release. Bioorg. Med. Chem. 2005, 13, 1725-38.
14. Saavedra, J. E.; Booth, M. N.; Hrabie, J. A.; Davies, K. M. & Keefer, L. K. Piperazine as a linker for incorporating the nitric oxide-releasing diazeniumdiolate group into other biomedically relevant functional molecules. J. Org. Chem. 1999, 64, 5124-31.
15. Abuo-Rahma, G. E. D. A. A.; Horstmann, A.; Radwan, M. F.; El-Emam, A.; Glusa, E. & Lehmann, J. NO-donors, part 9 [1]: Diazeniumdiolates inhibit human platelet aggregation and induce a transient vasodilatation of porcine pulmonary arteries in accordance with the NO-releasing rates. Eur. J. Med. Chem. 2005, 40, 281-7.
16. Cai, T. B.; Tang, X.; Nagorski, J.; Brauschweiger, P. G. & Wang, P. G. Synthesis and cytotoxicity of 5-fluorouracil/diazeniumdiolate conjugates. Bioorg. Med. Chem. 2003, 11, 4971-5.
17. Shami, P. J.; Saavedra, J, E.; Wang, L. Y.; Bonifant, C. L.; Diwan, B. A.; Singh, S. V.; Gu, Y.; Fox, S. D.; Buzard, G. S.; Citro, M. L.; Waterhouse, D. J.; Davies, K. M.; Ji, X. & Keefer, L. K. JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity. Mol. Cancer Ther. 2003, 2, 409-17.
18. Shami, P. J.; Udupi, V.; Yu, M.; Malaviya, S.; Saavedra, J. E. & Keefer, L. K. JS-K, a novel nitric oxide (NO) generator, induces cytochrome c release and caspase activation in HL-60 myeloid leukemia cells. Blood 2004, 104 (Suppl. 1), 931a.
19. Shami, P. J.; Kaur, G.; Thillainathan, J.; Jia, L.; Saavedra, J. E. & Keefer, L. K. JS-K, a novel nitric oxide (NO) generator, Shows potent anti-angiogenic activity. Blood 2004, 104 (Suppl. 1), 931a.
20. Ren, Z.; Kar, S.; Wang, Z.; Wang, M.; Saavedra, J. E. & Carr, B. I. JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathways. J. Cell Physiol. 2003, 197, 426-34.
21. Findlay, V. J.; Townsend, D. M.; Saavedra, J. E.; Buzard, G. S.; Citro, M. L.; Keefer, L. K.; Ji, X. & Tew, K. D. Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. Mol. Pharmacol. 2004, 65, 1070-9.
22. Liu, J.; Li, C.; Qu, W.; Leslie, E.; Bonifant, C. L.; Buzard, G. S.; Saavedra, J. E.; Keefer, L. K. & Waalkes, M. P. Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. Mol. Cancer Ther. 2004, 3, 709-14.
23. Saavedra, J. E.; Southan, G. J.; Davies, K. M.; Lundell, A.; Markou, C.; Hanson, S. R.; Adrie, C.; Hurford, W. E.; Zapol, W. M. & Keefer, L. K. Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J. Med. Chem. 1996, 39, 4361-5.
24. Keefer, L. K.; Nims, R, W.; Davies, K. M. & Wink, D. A. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms. Meth. Enzymol. 1996, 268, 281-93.
25. Davies, K. M.; Wink, D. A.; Saavedra, J. E. & Keefer, L. K. Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. J. Am. Chem. Soc. 2001, 123, 5473-81.
26. Diodati, J. G.; Quyyumi, A. A. & Keefer, L. K. Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: Hemodynamic effect in the rabbit. J. Cardiovasc. Pharmacol. 1993, 22, 287-92.
27. Mooradian, D. L.; Hutsell, T. C. & Keefer, L. K. Nitric oxide (NO) donor molecules: Effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J. Cardiovasc. Pharmacol. 1995, 25, 674-8.
28. Saavedra, J. E.; Shami, P. J.; Wang, L. Y.; Davies, K. M.; Booth, M. N.; Citro, M. L. & Keefer, L. K. Esterase-sensitive nitric oxide donors of the diazeniumdiolate family. In vitro antileukemic activity. J. Med. Chem. 2000, 43, 261-9.
29. Miranda, K. M.; Katori, T.; Torres de Holding, C. L.; Thomas, L.; Ridnour, L. A.; McLendon, W. J.; Dutton, A. S.; Champion, H. C.; Mancardi, D.; Tocchetti, C. G.; Saavedra, J. E.; Keefer, L. K.; Houk, K. N.; Fukuto, J. M.; Kass, D. A.; Paolocci, N. & Wink, D. A. Comparison of the NO and HNO donating properties of diazeniumdiolates: Primary amine adducts release HNO in vivo. J. Med. Chem. 2005, submitted.
30. 2-Substituted diazeniumdiolates. Free Radic. Biol. Med. 2004, 37, 745-52.
31. Smith, D. J. and Simmons, M. L. Transdermal delivery of nitric oxide from diazeniumdiolates. J. Control. Release 1998, 51, 153-9.
32. Cetin, M.; Duran, B.; Demirkoprulu, N.; Guvenal, T.; Erden, O. & Cetin, A. Effects of diazeniumdiolates (NONOates) and methylene blue on the reduction of postoperative adhesion in rats. Gynecol. Obstet. Invest. 2004, 57, 186-90.
33. Dashti, N.; Ansari, M.; Shabani, M.; Vardasti, S.; Mirsalehian, A.; Noori Mughehi, M. H. & Hatmi, Z. N. The effect of nitric oxide donor in diabetic wound healing. Iranian J. Publ. Health 2003, 32, 59-63.
34. Gabikian, P.; Clatterbuck, R. E.; Eberhart, C. G.; Tyler, B. M.; Tierney, T. S. & Tamargo, R. J. Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: Toxicity and efficacy studies in rabbits and rats. Stroke 2002, 33, 2681-6.
35. Pradilla, G.; Thai, Q. A.; Legnani, F. G.; Hsu, W.; Kretzer, R. M.; Wang, P. P. & Tamargo, R. J. Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits. Neurosurgery 2004, 55, 1393-400.
36. Tierney, T. S.; Clatterbuck, R. E.; Lawson, C.; Thai, Q.-A.; Rhines, L. D. & Tamargo, R. J. Prevention and reversal of experimental posthemorrhagic vasospasm by the periadventitial administration of nitric oxide from a controlled-release polymer. Neurosurgery 2001, 49, 945-53.
37. Badiyan, D.; Wills, R. B. H. & Bowyer, M. C. Use of a nitric oxide donor compound to extend the vase life of cut flowers. HortScience 2004, 39, 1371-2.
38. Bowyer, M. C.; Wills, R. B. H.; Badiyan, D. & Ku, V. V. V. Extending the postharvest life of carnations with nitric oxide-Comparison of fumigation and in vivo delivery. Postharvest Biol. Technol. 2003, 30, 281-6.
39. Waterhouse, D. J.; Saavedra, J. E.; Davies, K. M.; Citro, M. L.; Xu, X.; Powell, D. A.; Grimes, G. J.; Potti, G. K. & Keefer, L. K. Injectable formulation of disodium 1-[2-(carboxylato)pyrrolidin-1-yl] diazen-1-ium-1,2-diolate (PROLI/NO), an ultrafast nitric oxide donor prodrug. J. Pharm. Sci. 2005, submitted.
40. Annich, G. M.; Meinhardt, J, P.; Mowery, K. A.; Ashton, B. A.; Merz, S. I.; Hirschl, R. B.; Meyerhoff, M. E. & Bartlett, R. H. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit. Care Med. 2000, 28, 915-20.
41. Zhang, H.; Annich, G. M.; Miskulin, J.; Stankiewicz, K.; Osterholzer, K.; Merz, S. I.; Bartlett, R. H. & Meyerhoff, M. E. Nitric oxide-releasing fumed silica particles: Synthesis, characterization, and biomedical application. J. Am. Chem. Soc. 2003, 125, 5015-24.
42. - group. J. Med. Chem. 1996, 39, 1148-56.
43. Chaux, A.; Ruan, X. M.; Fishbein, M. C.; Ouyang, Y.; Kaul, S.; Pass, J. A. & Matloff, J. M. Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation. J. Thorac. Cardiovasc. Surg. 1998, 115, 604-14.
44. Parzuchowski, P. G.; Frost, M. C. & Meyerhoff, M. E. Synthesis and characterization of polymethacrylate-based nitric oxide donors. J. Am. Chem. Soc. 2002, 124, 12182-91.
45. Frost, M. C.; Rudich, S. M.; Zhang, H.; Maraschio, M. A. & Meyerhoff, M. E. In vivo biocompatibility and analytical performance of intravascular amperometric oxygen sensors prepared with improved nitric oxide-releasing silicone rubber coating. Anal. Chem. 2002, 74, 5942-7.
46. Schoenfisch, M. H.; Mowery, K. A.; Rader, M. V.; Baliga, N.; Wahr, J. A. & Meyerhoff, M. E. Improving the thromboresistivity of chemical sensors via nitric oxide release: Fabrication and in vivo evaluation of NO-releasing oxygen-sensing catheters. Anal. Chem. 2000, 72, 1119-26.
47. Yin, Z. L. and Dusting, G. J. A nitric oxide donor (spermine-NONOate) prevents the formation of neointima in rabbit carotid artery. Clin. Exp. Pharmacol. Physiol. 1997, 24, 436-8.
48. Kaul, S.; Cercek, B.; Rengstrom, J.; Xu, X.-P.; Molloy, M. D.; Dimayuga, P.; Parikh, A. K.; Fishbein, M. C.; Nilsson, J.; Rajavashisth, T. B. & Shah, P. K. Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: Role of nuclear factor-kappaB. J. Am. Coll. Cardiol. 2000, 35, 493-501.
49. Chen, C.; Hanson, S. R.; Keefer, L. K.; Saavedra, J. E.; Davies, K. M.; Hutsell, T. C.; Hughes, J. D.; Ku, D. N. & Lumsden, A. B. Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery. J. Surg. Res. 1997, 67, 26-32.
50. Hampl, V.; Tristani-Firouzi, M.; Hutsell, T. C. & Archer, S. L. Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension. Cardiovasc. Res. 1996, 31, 55-62.
51. Adrie, C.; Hirani, W. M.; Holzmann, A.; Keefer, L.; Zapol, W. M. & Hurford, W. E. Selective pulmonary vasodilation by intravenous infusion of an ultrashort half-life nucleophile/nitric oxide adduct. Anesthesiology 1998, 88, 190-5.
52. Vanderford, P. A.; Wong, J.; Chang, R.; Keefer, L. K.; Soifer, S. J. & Fineman, J. R. Diethylamine/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and systemic vasodilation in intact newborn lambs. J. Cardiovasc. Pharmacol. 1994, 23, 113-9.
53. Cornfield, D. N.; Martin, E. B.; Hampl, V. & Archer, S. L. Aerosol delivery of diethylenetriamine/nitric oxide, a nitric oxide adduct, causes selective pulmonary vasodilation in perinatal lambs. J. Lab. Clin. Med. 1999, 134, 419-25.
54. Young, K. C.; Ladino, J.; Navarrete, C.; Dabrowska, K.; Hehre, D.; Bancalari, E. & Suguihara, C. The effect of a nebulized NO donor, DPTA/NO, on acute hypoxic pulmonary hypertension in newborn piglets. Biol. Neonate 2004, 85, 195-202.
55. Jacobs, B. R.; Brilli, R. J.; Ballard, E. T.; Passerini, D. J. & Smith, D. J. Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury. Am. J. Respir. Crit. Care Med. 1998, 158, 1536-42.
56. Brilli, R. J.; Krafte-Jacobs, B.; Smith, D. J.; Roselle, D.; Passerini, D.; Vromen, A.; Moore, L.; Szabó, C. & Salzman, A. L. Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension. J. Appl. Physiol. 1997, 83, 1968-75.
57. Brilli, R. J.; Krafte-Jacobs, B.; Smith, D. J.; Passerini, D.; Moore, L. & Ballard, E. T. Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension. Crit. Care Med. 1998, 26, 1390-6.
58. Jacobs, B. R.; Smith, D. J.; Zingarelli, B.; Passerini, D. J.; Ballard, E. T. & Brilli, R. J. Soluble nitric oxide donor and surfactant improve oxygenation and pulmonary hypertension in porcine lung injury. Nitric Oxide Biol. Chem. 2000, 4, 412-22.
59. De Witt, B. J.; Marrone, J. R.; Kaye, A. D.; Keefer, L. K. & Kadowitz, P. J. Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed. Eur. J. Pharmacol. 2001, 430, 311-5.
60. Liu, J.; Li, C.; Waalkes, M. P.; Clark, J.; Myers, P.; Saavedra, J. E. & Keefer, L. K. The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice. Hepatology 2003, 37, 324-33.
61. Li, C.; Liu, J.; Saavedra, J. E.; Keefer, L. K. & Waalkes, M. P. The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced nephrotoxicity in mice. Toxicology 2003, 189, 173-80.
62. 2-Vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate protection against D-galactosamine/endotoxin-induced hepatotoxicity in mice: Genomic analysis using microarrays. J. Pharmacol. Exp. Ther. 2002, 300, 18-25.
63. Kirov, M. Y.; Evgenov, O. V.; Kuklin, V. N.; Virág, L.; Pacher, P.; Southan, G. J.; Salzman, A. L.; Szabó, C. & Bjertnaes, L. J. Aerosolized linear polyethylenimine-nitric oxide /nucleophile adduct attenuates endotoxin-induced lung injury in sheep. Am. J. Respir. Crit. Care Med. 2002, 166, 1436-42.
64. Saavedra, J. E.; Billiar, T. R.; Williams, D. L.; Kim, Y.-M.; Watkins, S. C. & Keefer, L. K. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-α-induced apoptosis and toxicity in the liver. J. Med. Chem. 1997, 40, 1947-54.
65. Ricciardi, R.; Foley, D. P.; Quarfordt, S. H.; Saavedra, J. E.; Keefer, L. K.; Wheeler, S. M.; Donohue, S. E.; Callery, M. P. & Meyers, W. C. V-PYRRO/NO: An hepato-selective nitric oxide donor improves porcine liver hemodynamics and function after ischemia reperfusion. Transplantation 2001, 71, 193-8.
66. Du, Z. Y.; Hicks, M.; Jansz, P.; Rainer, S.; Spratt, P. & Macdonald, P. The nitric oxide donor, diethylamine NONOate, enhances preservation of the donor rat heart. J. Heart Lung Transplant. 1998, 17, 1113-20.
67. Champion, H. C.; Bivalacqua, T. J.; Wang, R.; Kadowitz, P. J.; Keefer, L. K.; Saavedra, J. E.; Hrabie, J. A.; Doherty, P. C. & Hellstrom, W. J. G. Induction of penile erection by intracavernosal and transurethral administration of novel nitric oxide donors in the cat. J. Urol. 1999, 161, 2013-9.
68. Pacher, P.; Mabley, J. G.; Liaudet, L.; Evgenov, O. V.; Southan, G. J.; Abdelkarim, G. E.; Szabó, C. & Salzman, A. L. Topical administration of a novel nitric oxide donor, linear polyethylenimine-nitric oxide/nucleophile adduct (DS1), selectively increases vaginal blood flow in anesthetized rats. Int. J. Impot. Res. 2003, 15, 461-4.
69. Pluta, R. M.; Oldfield, E. H. & Boock, R. J. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J. Neurosurg. 1997, 87, 746-51.
70. Wolf, E. W.; Banerjee, A.; Soble-Smith, J.; Dohan, F. C.; Jr.; White, R. P. & Robertson, J. T. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J. Neurosurg. 1998, 89, 279-88.
71. Masters, K. S. B.; Leibovich, S. J.; Belem, P.; West, J. L. & Poole-Warren, L. A. Effects of nitric oxide releasing poly(vinyl alcohol) hydrogel dressings on dermal wound healing in diabetic mice. Wound Rep. Regen. 2002, 10, 286-94.
72. Diwan, A. D.; Wang, M. X.; Jang, D.; Zhu, W. & Murrell, G. A. C. Nitric oxide modulates fracture healing. J. Bone Miner. Res. 2000, 15, 342-51.
73. Fouad Ahmed, S.; Oswald, I. P.; Caspar, P.; Hieny, S.; Keefer, L.; Sher, A. & James, S. L. Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni. Infect. Immun. 1997, 65, 219-26.
74. Rajan, T. V,; Porte, P.; Yates, J. A.; Keefer, L. & Shultz, L. D. Role of nitric oxide in host defense against an extracellular, metazoan parasite. Brugia malayi, Infect. Immun. 1996, 64, 3351-3.
75. Stinson, S. F.; House, T.; Bramhall, C.; Saavedra, J. E.; Keefer, L. K. & Nims, R. W. Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL /6 mouse. Xenobiotica 2002, 32, 339-47.
76. Inami, K.; Nims, R. W.; Srinivasan, A.; Citro, M. L.; Saavedra, J. E.; Cederbaum, A. I. & Keefer, L. K. Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450. Nitric Oxide Biol. Chem. 2005, submitted.
77. Wu, X.; Tang, X.; Xian, M. & Wang, P. G. Glycosylated diazeniumdiolates: A novel class of enzyme-activated nitric oxide donors. Tetrahedron Lett. 2001, 42, 3779-82.
78. -ion. J. Am. Chem. Soc. 2004, 126, 12880-7.
79. Cai, T. B.; Lu, D.; Landerholm, M. & Wang, P. G. Sialated diazeniumdiolate: A new sialidase-activated nitric oxide donor. Org. Lett. 2004, 6, 4203-5.
80. Tang, X.; Xian, M.; Trikha, M.; Honn, K. V. & Wang, P. G. Synthesis of peptide-diazeniumdiolate conjugates: Towards enzyme activated antitumor agents. Tetrahedron Lett. 2001, 42, 2625-9.
81. Mowery, K. A.; Schoenfisch, M. H.; Saavedra, J. E.; Keefer, L. K. & Meyerhoff, M. E. Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials 2000, 21, 9-21.
82. Jun, H.-W.; Taite, L. J. & West, J. L. Nitric oxide-producing polyurethanes. Biomacromolecules 2005, 6, 838-44.
83. Mowery, K. A.; Schoenfisch, M. H.; Baliga, N.; Wahr, J. A. & Meyerhoff, M. E. More biocompatible electrochemical sensors using nitric oxide release polymers. Electroanalysis 1999, 11, 681-6.
84. Reynolds, M. M.; Frost, M. C. & Meyerhoff, M. E. Nitric oxide-releasing hydrophobic polymers: Preparation, characterization, and potential biomedical applications. Free Radic. Biol. Med. 2004, 37, 926-36.
85. Nablo, B. J. and Schoenfisch, M. H. In vitro cytotoxicity of nitric oxide-releasing sol-gel derived materials. Biomaterials 2005, 26, 4405-15.
86. Marxer, S. M.; Robbins, M. E. & Schoenfisch, M. H. Sol-gel derived nitric oxide-releasing oxygen sensors. Analyst 2005, 130, 206-12.
87. Shin, J. H.; Marxer, S. M. & Schoenfisch, M. H. Nitric oxide-releasing sol-gel particle/polyurethane glucose biosensors. Anal. Chem. 2004, 76, 4543-9.
88. Pulfer, S. K.; Ott, D. & Smith, D. J. Incorporation of nitric oxide-releasing crosslinked polyethyleneimine microspheres into vascular grafts. J. Biomed. Mater. Res. 1997, 37, 182-9.
89. Nablo, B. J.; Rothrock, A. R. & Schoenfisch, M. H. Nitric oxide-releasing sol-gels as antibacterial coatings for orthopedic implants. Biomaterials 2005, 26, 917-24.
90. Nablo, B. J. and Schoenfisch, M. H. Poly(vinyl chloride)-coated sol-gels for studying the effects of nitric oxide release on bacterial adhesion. Biomacromolecules 2004, 5, 2034-41.
91. Nablo, B. J. and Schoenfisch, M. H. Antibacterial properties of nitric oxide-releasing sol-gels. J. Biomed. Mater. Res. A 2003, 67, 1276-83.
92. Marxer, S. M.; Rothrock, A. R.; Nablo, B. J.; Robbins, M. E. & Schoenfisch, M. H. Preparation of nitric oxide (NO)-releasing sol-gels for biomaterial applications. Chem. Materials 2003, 15, 4193-9.
93. Robbins, M. E. and Schoenfisch, M. H. Surface-localized release of nitric oxide via sol-gel chemistry. J. Am. Chem. Soc. 2003, 125, 6068-9.
94. Nablo, B. J.; Chen, T.-Y. & Schoenfisch, M. H. Sol-gel derived nitric-oxide releasing materials that reduce bacterial adhesion. J. Am. Chem. Soc. 2001, 123, 9712-3.
95. Schoenfisch, M. H.; Zhang, H.; Frost M. C. & Meyerhoff, M. E. Nitric oxide-releasing fluorescence-based oxygen sensing polymeric films. Anal. Chem. 2002, 74, 5937-41.
96. Zhang, H.; Annich, G. M.; Miskulin, J.; Osterholzer, K.; Merz, S. I.; Bartlett, R. H. & Meyerhoff, M. E. Nitric oxide releasing silicone rubbers with improved blood compatibility: Preparation, characterization, and in vivo evaluation. Biomaterials 2002, 23, 1485-94.
97. Keefer, L. K. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 585-607.